Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.5200
+0.0100 (1.96%)
Sep 4, 2026, 2:45 PM CET
Neola Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.03 | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 |
Cash & Short-Term Investments | 4.03 | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 |
Cash Growth | -84.80% | -17.56% | -9.38% | -46.17% | 74.76% | 37.80% |
Other Receivables | - | 0.68 | 1.07 | 20.9 | 1.02 | 1.45 |
Receivables | 33.12 | 0.68 | 1.07 | 20.9 | 1.02 | 1.45 |
Prepaid Expenses | - | 0.44 | 0.42 | 0.63 | 0.49 | 0.4 |
Other Current Assets | - | - | - | - | -0 | - |
Total Current Assets | 37.15 | 17.24 | 21.04 | 43.11 | 41.6 | 24.79 |
Property, Plant & Equipment | 0.19 | 0.22 | 0.2 | 0.14 | 0.22 | 0.16 |
Long-Term Deferred Charges | 66.96 | 61.22 | 52.37 | 42.78 | 33.51 | 18.88 |
Other Long-Term Assets | 0.15 | 0.13 | - | - | - | 0 |
Total Assets | 104.45 | 78.8 | 73.61 | 86.02 | 75.33 | 43.83 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 0.91 | 1.07 | 2.18 | 1.49 | 1.3 |
Accrued Expenses | 4.38 | 1.56 | 2 | 1.62 | 1.79 | 1.44 |
Current Income Taxes Payable | - | 0.1 | 0.1 | 0.09 | 0.08 | 0.05 |
Other Current Liabilities | 2.47 | 0.43 | 1.49 | 2.27 | 1.98 | 0.41 |
Total Current Liabilities | 6.86 | 3 | 4.65 | 6.16 | 5.35 | 3.19 |
Other Long-Term Liabilities | - | - | - | 0.83 | 2.5 | - |
Total Liabilities | 6.86 | 3 | 4.65 | 6.99 | 7.85 | 3.19 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 97.59 | 5.57 | 5.01 | 3.98 | 3.98 | 1.5 |
Additional Paid-In Capital | - | 116.38 | 99.08 | 80.11 | 79.56 | 44.83 |
Retained Earnings | - | -46.15 | -35.13 | -25.06 | -16.05 | -5.7 |
Comprehensive Income & Other | - | - | - | 20 | - | - |
Shareholders' Equity | 97.59 | 75.8 | 68.96 | 79.03 | 67.49 | 40.63 |
Total Liabilities & Equity | 104.45 | 78.8 | 73.61 | 86.02 | 75.33 | 43.83 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 4.03 | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 |
Net Cash Growth | -84.80% | -17.56% | -9.38% | -46.17% | 74.76% | 37.80% |
Net Cash Per Share | 0.05 | 0.21 | 0.28 | 0.39 | 1.54 | 1.64 |
Filing Date Shares Outstanding | 77.95 | 77.95 | 70.15 | 70.15 | 55.69 | 21.05 |
Total Common Shares Outstanding | 77.95 | 77.95 | 70.15 | 55.69 | 55.69 | 21.05 |
Working Capital | 30.3 | 14.24 | 16.39 | 36.95 | 36.26 | 21.59 |
Book Value Per Share | 1.25 | 0.97 | 0.98 | 1.42 | 1.21 | 1.93 |
Tangible Book Value | 97.59 | 75.8 | 68.96 | 79.03 | 67.49 | 40.63 |
Tangible Book Value Per Share | 1.25 | 0.97 | 0.98 | 1.42 | 1.21 | 1.93 |
Machinery | - | 0.52 | 0.46 | 0.31 | 0.31 | 0.2 |